Protagonist Non Current Liabilities Total vs Property Plant And Equipment Net Analysis

PTGX Stock  USD 40.58  0.67  1.62%   
Protagonist Therapeutics financial indicator trend analysis is much more than just breaking down Protagonist Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Protagonist Therapeutics is a good investment. Please check the relationship between Protagonist Therapeutics Non Current Liabilities Total and its Property Plant And Equipment Net accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagonist Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Protagonist Stock please use our How to Invest in Protagonist Therapeutics guide.

Non Current Liabilities Total vs Property Plant And Equipment Net

Non Current Liabilities Total vs Property Plant And Equipment Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Protagonist Therapeutics Non Current Liabilities Total account and Property Plant And Equipment Net. At this time, the significance of the direction appears to have very week relationship.
The correlation between Protagonist Therapeutics' Non Current Liabilities Total and Property Plant And Equipment Net is 0.26. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Property Plant And Equipment Net in the same time period over historical financial statements of Protagonist Therapeutics, assuming nothing else is changed. The correlation between historical values of Protagonist Therapeutics' Non Current Liabilities Total and Property Plant And Equipment Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Protagonist Therapeutics are associated (or correlated) with its Property Plant And Equipment Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant And Equipment Net has no effect on the direction of Non Current Liabilities Total i.e., Protagonist Therapeutics' Non Current Liabilities Total and Property Plant And Equipment Net go up and down completely randomly.

Correlation Coefficient

0.26
Relationship DirectionPositive 
Relationship StrengthVery Weak

Non Current Liabilities Total

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.
Most indicators from Protagonist Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Protagonist Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagonist Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Protagonist Stock please use our How to Invest in Protagonist Therapeutics guide.Enterprise Value is likely to rise to about 1.2 B in 2024, whereas Selling General Administrative is likely to drop slightly above 18 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Income443K4.1M12.9M13.6M
Net Interest Income443K4.1M12.9M13.6M

Protagonist Therapeutics fundamental ratios Correlations

0.810.83-0.25-0.040.990.72-0.87-0.850.390.870.520.251.00.50.940.960.23-0.030.830.820.3-0.80.871.00.1
0.810.61-0.35-0.510.860.43-0.75-0.680.280.720.31-0.20.820.110.760.770.310.070.90.750.35-0.560.670.810.09
0.830.61-0.450.20.830.77-0.69-0.620.550.710.710.540.820.40.730.790.210.110.690.50.29-0.690.720.820.21
-0.25-0.35-0.45-0.16-0.35-0.52-0.090.0-0.570.09-0.58-0.26-0.240.53-0.24-0.32-0.56-0.67-0.470.07-0.590.22-0.39-0.24-0.01
-0.04-0.510.2-0.16-0.120.490.280.050.19-0.220.240.81-0.070.23-0.010.05-0.050.31-0.19-0.26-0.03-0.240.22-0.050.08
0.990.860.83-0.35-0.120.7-0.84-0.810.440.830.560.20.990.390.910.960.280.020.870.790.34-0.770.840.980.03
0.720.430.77-0.520.490.7-0.41-0.590.410.460.540.550.70.260.680.830.260.440.720.510.32-0.750.860.710.19
-0.87-0.75-0.69-0.090.28-0.84-0.410.91-0.26-1.0-0.3-0.07-0.87-0.66-0.86-0.74-0.230.39-0.63-0.89-0.280.71-0.66-0.87-0.19
-0.85-0.68-0.620.00.05-0.81-0.590.91-0.25-0.92-0.28-0.14-0.86-0.64-0.92-0.8-0.410.24-0.66-0.95-0.450.84-0.85-0.86-0.17
0.390.280.55-0.570.190.440.41-0.26-0.250.260.380.640.390.170.40.370.380.350.240.080.42-0.620.320.390.08
0.870.720.710.09-0.220.830.46-1.0-0.920.260.310.120.870.690.860.760.22-0.370.630.890.27-0.740.690.870.2
0.520.310.71-0.580.240.560.54-0.3-0.280.380.310.360.510.040.390.50.37-0.060.390.20.42-0.250.440.49-0.36
0.25-0.20.54-0.260.810.20.55-0.07-0.140.640.120.360.230.460.250.27-0.020.28-0.02-0.110.03-0.540.310.240.17
1.00.820.82-0.24-0.070.990.7-0.87-0.860.390.870.510.230.490.940.960.24-0.040.830.830.3-0.790.861.00.1
0.50.110.40.530.230.390.26-0.66-0.640.170.690.040.460.490.50.42-0.22-0.490.080.53-0.19-0.620.350.50.07
0.940.760.73-0.24-0.010.910.68-0.86-0.920.40.860.390.250.940.50.880.43-0.020.760.850.48-0.860.920.950.24
0.960.770.79-0.320.050.960.83-0.74-0.80.370.760.50.270.960.420.880.180.140.890.790.24-0.80.90.960.05
0.230.310.21-0.56-0.050.280.26-0.23-0.410.380.220.37-0.020.24-0.220.430.180.070.250.331.0-0.320.450.220.08
-0.030.070.11-0.670.310.020.440.390.240.35-0.37-0.060.28-0.04-0.49-0.020.140.070.31-0.270.08-0.160.21-0.030.33
0.830.90.69-0.47-0.190.870.72-0.63-0.660.240.630.39-0.020.830.080.760.890.250.310.730.3-0.620.820.830.12
0.820.750.50.07-0.260.790.51-0.89-0.950.080.890.2-0.110.830.530.850.790.33-0.270.730.36-0.710.780.820.09
0.30.350.29-0.59-0.030.340.32-0.28-0.450.420.270.420.030.3-0.190.480.241.00.080.30.36-0.370.50.290.09
-0.8-0.56-0.690.22-0.24-0.77-0.750.710.84-0.62-0.74-0.25-0.54-0.79-0.62-0.86-0.8-0.32-0.16-0.62-0.71-0.37-0.83-0.8-0.24
0.870.670.72-0.390.220.840.86-0.66-0.850.320.690.440.310.860.350.920.90.450.210.820.780.5-0.830.870.21
1.00.810.82-0.24-0.050.980.71-0.87-0.860.390.870.490.241.00.50.950.960.22-0.030.830.820.29-0.80.870.12
0.10.090.21-0.010.080.030.19-0.19-0.170.080.2-0.360.170.10.070.240.050.080.330.120.090.09-0.240.210.12
Click cells to compare fundamentals

Protagonist Therapeutics Account Relationship Matchups

Protagonist Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets154.9M324.5M347.7M247.9M358.0M204.1M
Other Current Liab(10.2M)19.8M36.4M22.5M18.2M12.7M
Total Current Liabilities35.4M40.2M44.0M31.2M21.3M27.7M
Total Stockholder Equity(217.7M)(283.8M)(409.4M)(536.8M)336.7M353.5M
Net Tangible Assets80.0M279.6M300.0M215.6M247.9M141.3M
Property Plant And Equipment Net7.7M6.4M6.7M4.6M2.1M3.4M
Net Debt(16.0M)(111.4M)(117.8M)(122.1M)(185.6M)(176.3M)
Retained Earnings(217.7M)(283.8M)(409.4M)(536.8M)(615.7M)(584.9M)
Accounts Payable2.8M3.1M1.6M3.6M772K733.4K
Cash33.0M117.4M123.7M125.7M186.7M196.1M
Non Current Assets Total9.6M8.9M7.0M10.6M2.4M2.3M
Other Assets450K1.1M1.9M225K258.8K245.8K
Cash And Short Term Investments133.0M307.8M326.9M237.4M341.6M191.4M
Net Receivables6.8M2.4M1.6M52K10.3M10.8M
Common Stock Shares Outstanding25.9M34.4M46.3M49.0M56.8M29.8M
Short Term Investments100.0M188.5M203.2M111.6M154.9M99.8M
Liabilities And Stockholders Equity(142.7M)(238.9M)(361.7M)247.9M358.0M375.8M
Non Current Liabilities Total39.5M4.6M3.7M784.7M221K210.0K
Inventory4.8M4.0M8.5M(94K)(10.3M)(9.8M)
Other Current Assets744K7.4M12.3M5.7M3.6M3.6M
Other Stockholder Equity221K563.4M709.7M752.7M952.5M1.0B
Total Liab75.0M44.9M47.7M784.7M21.3M20.2M
Property Plant And Equipment Gross7.7M6.4M11.0M9.9M8.4M5.1M
Total Current Assets145.3M315.6M340.7M237.4M355.6M196.9M
Accumulated Other Comprehensive Income(221K)28K(299K)(359K)(105K)(110.3K)
Property Plant Equipment7.7M1.5M6.7M1.6M1.8M2.5M
Capital Surpluse297.8M563.4M709.7M752.7M865.6M908.9M
Retained Earnings Total Equity(217.7M)(283.8M)(409.4M)(536.8M)(483.1M)(458.9M)
Current Deferred Revenue41.5M14.5M1.6M69K3K2.9K
Net Invested Capital89.8M279.6M300.0M215.6M336.7M228.6M
Net Working Capital109.9M275.4M296.7M211.9M334.3M227.5M
Short Term Debt1.3M2.9M4.4M5.0M2.3M3.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Protagonist Stock Analysis

When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.